A Long-Term Follow-Up Study of Participants Exposed to REACT (NCT05918523)
A Long-Term Follow-up Study of Participants Exposed to Renal Autologous Cell Therapy From Studies RMCL-002, REGEN-003, REGEN-004
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to evaluate the long-term safety of up to two gelatin-hydrogel formulation REACT injections given 3 to 6 months apart and delivered percutaneously into same kidney on renal function in participants with chronic kidney disease (CKD).
Who can join: Review the eligibility criteria below.
Location: Boise Kidney & Hypertension Institute — Meridian, Idaho
Age range: 30 Years to 80 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Boise Kidney & Hypertension Institute — Meridian, Idaho
📞 Contact the Study Coordinator
Phone: (336) 999-7031
Email: info@prokidney.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Diabetic Kidney Disease
- Decision Impact Trial of KidneyIntelX — Slingerlands, New York
- Prospective Decision Impact Trial of KidneyIntelX — Winston-Salem, North Carolina
- Pentoxifylline in Diabetic Kidney Disease — Phoenix, Arizona
- Prospective Decision Impact Clinical Utility Trial of KidneyIntelX — New York, New York
- Revealing Engagement Dynamics Among Diabetic Kidney Disease Patients — San Francisco, California
- Role of Finerenone in African American Veterans With Diabetic Kidney Disease — Washington D.C., District of Columbia
Explore by condition: All Diabetic Kidney Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.